Losartan Cost in Ohio (2026): Cash Prices, Medicaid, Insurance, and Discount Options

How Much Does Losartan Cost in Ohio in 2026?
At a glance
- Average Ohio cash price / $10 per month for generic losartan (2026)
- Manufacturer list price / $80 per month (Merck Cozaar and authorized generics)
- Ohio Medicaid / Covers losartan for hypertension and qualifying conditions
- Dosing / Once daily oral tablet, typically 25 mg to 100 mg
- Compounding access / Legal via licensed 503A pharmacies in Ohio
- Telehealth prescribing / Permitted in Ohio for losartan
- Common doses dispensed / 25 mg, 50 mg, 100 mg tablets
- FDA-approved uses / Hypertension, diabetic nephropathy (type 2), stroke risk reduction in LVH
- Generic availability / Since 2010; multiple manufacturers
Ohio Cash Prices for Losartan in 2026
The average cash-pay price for a 30-day supply of generic losartan at Ohio retail pharmacies is approximately $10 in 2026. That price holds fairly consistent across major chains in Columbus, Cleveland, Cincinnati, and Toledo, though individual pharmacies may charge anywhere from $4 to $18 depending on dose strength and quantity.
Merck's branded Cozaar carries a list price around $80 per month, but prescribers almost universally write for generic losartan potassium at this point. The patent expired in 2010, and more than a dozen generic manufacturers supply the U.S. market. This competition is the reason prices dropped over 85% from the branded original. According to FDA's Orange Book listings, numerous AB-rated generic formulations are therapeutically equivalent to Cozaar across all tablet strengths. Pharmacy markup varies. Large chains (CVS, Walgreens, Kroger pharmacy) tend to cluster near that $10 average. Independent pharmacies sometimes price slightly higher but may negotiate on cash-pay transactions.
Worth noting: the $10 average is for the most commonly prescribed strength of 50 mg. The 100 mg tablet may cost $1 to $3 more per month at some locations, while the 25 mg starter dose often costs the same or less than the 50 mg.
Ohio Medicaid Coverage for Losartan
Ohio Medicaid does cover losartan for its FDA-approved indications, which include hypertension, reduction of stroke risk in patients with left ventricular hypertrophy, and diabetic nephropathy in patients with type 2 diabetes. Coverage restrictions exist for certain uses. If losartan is being prescribed exclusively for a type 2 diabetes indication without a concurrent hypertension or nephropathy diagnosis, prior authorization may apply.
Ohio's managed Medicaid plans (CareSource, Molina, Buckeye Health Plan, UnitedHealthcare Community Plan, Anthem, and AmeriHealth Caritas) each maintain their own preferred drug lists, but generic losartan appears on virtually all of them as a Tier 1 medication. Copays under Ohio Medicaid for Tier 1 generics are typically $0 to $3 per fill.
The 2017 ACC/AHA Hypertension Guideline identifies ARBs including losartan as first-line therapy for hypertension, particularly in patients who cannot tolerate ACE inhibitors due to cough or angioedema. That guideline support strengthens coverage determinations across payers. Ohio Medicaid enrollment stood at approximately 3.4 million beneficiaries as of early 2026, and ARBs like losartan rank among the most frequently dispensed medication classes in the program.
For beneficiaries on the fee-for-service track rather than managed care, the Ohio Department of Medicaid's Unified Preferred Drug List applies. Generic losartan has maintained preferred status on that list without interruption.
Insurance Coverage Beyond Medicaid
Private insurers operating in Ohio, including Anthem Blue Cross Blue Shield, Medical Mutual, SummaCare, and marketplace plans sold through Healthcare.gov, consistently place generic losartan on Tier 1 formularies. Tier 1 copays in Ohio commercial plans typically range from $0 to $15 per month, depending on the plan design.
Medicare Part D plans available to Ohio residents follow a similar pattern. Generic losartan falls under the $0 to $10 copay range in the initial coverage phase for most standalone Part D plans and Medicare Advantage prescription drug plans. The Inflation Reduction Act's $2,000 annual out-of-pocket cap that took full effect in 2025 means even beneficiaries using multiple medications are unlikely to face cost barriers for losartan specifically.
Employer-sponsored plans dominate Ohio's insured population. Companies headquartered in Ohio (Procter & Gamble, Progressive, Nationwide) contract with pharmacy benefit managers (PBMs) that negotiate rebates. For a generic this inexpensive, most PBMs pass through the full discount to the plan. Some self-insured employers offer $0 copay generic programs that include losartan.
If your insurance copay exceeds $10, paying cash without using your insurance benefit may actually cost less. Ask the pharmacist to run both prices before swiping your card.
The LIFE Trial and Why Losartan Remains a Preferred ARB
Losartan's clinical profile rests on a strong evidence base. The landmark LIFE trial (Losartan Intervention For Endpoint reduction in hypertension) enrolled 9,193 patients aged 55 to 80 with hypertension and ECG evidence of left ventricular hypertrophy. Published in The Lancet in 2002, the study compared losartan-based therapy to atenolol-based therapy over a mean follow-up of 4.8 years.
Results were definitive. Losartan reduced the composite primary endpoint of cardiovascular death, stroke, and myocardial infarction by 13% compared to atenolol (relative risk 0.87, P=0.021). The stroke reduction was even more striking: a 25% relative risk reduction. These benefits occurred despite similar blood pressure reduction in both groups, suggesting losartan's advantages extended beyond simple pressure lowering.
Dr. Björn Dahlöf, LIFE's lead investigator, stated at the time of publication: "These findings demonstrate that the choice of antihypertensive agent matters beyond blood pressure control alone." That principle, now validated across multiple ARB trials, is one reason the 2017 ACC/AHA guideline and the JNC 8 panel recommendations maintain ARBs as first-line options.
For Ohio patients specifically, the combination of strong evidence, generic availability, and low cost makes losartan a practical first choice. A medication that costs $10 per month, has a once-daily dosing schedule, and reduced stroke risk by 25% in a 9,000-patient trial is hard to argue against.
Compounded Losartan in Ohio: Legal and Available
Compounded losartan is legal in Ohio when prepared by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Ohio's State Board of Pharmacy regulates these facilities under ORC Chapter 4729, and federal oversight comes from the FDA's 503A provisions under the Drug Quality and Security Act of 2013.
Why compound losartan when generic tablets cost $10? A few reasons apply. Pediatric patients who cannot swallow tablets may need a liquid suspension. Patients with specific excipient allergies (certain dyes, lactose, specific fillers) may require a custom formulation. Some patients on complex regimens benefit from combination compounding that puts multiple medications into a single dosage form.
Compounded losartan pricing through Ohio 503A pharmacies varies, but several facilities offer oral suspensions in the $15 to $30 range per month. Some compounding pharmacies advertise losartan suspensions at no additional cost above their dispensing fee when bundled with other compounded medications. The $0 per month figure that appears in some databases reflects specific promotional pricing from compounders seeking new patients and should not be assumed as a universal price point.
Ohio has approximately 200 licensed compounding pharmacies, concentrated in the Columbus, Cleveland, and Cincinnati metro areas but also operating in smaller cities like Akron, Dayton, and Youngstown. Telepharmacy rules in Ohio allow some compounding orders to be initiated remotely, broadening access for rural patients.
Discount Programs and Savings Cards
Several pathways exist to reduce losartan costs below the $10 Ohio average.
GoodRx and similar aggregators. Discount card platforms aggregate pricing from Ohio pharmacies and frequently display prices of $4 to $8 for a 30-day supply of losartan 50 mg. These prices are available to anyone regardless of insurance status. The cards work by routing the transaction through a contracted PBM at a negotiated rate.
Kroger Rx Savings Club. Kroger operates more than 250 pharmacy locations across Ohio. Their savings club ($36 per year for an individual, $72 for a family) includes generic losartan at a fixed $4 per 30-day supply across all strengths.
Walmart $4 Generics. Walmart pharmacies in Ohio include losartan on their $4 for 30 days and $10 for 90 days generic list. With over 100 Walmart pharmacy locations in Ohio, this is one of the most accessible discount options, especially in suburban and rural areas.
Costco Pharmacy. Ohio Costco locations do not require a membership to use the pharmacy (federal law). Generic losartan typically runs $5 to $7 for 30 tablets at Costco pharmacies in Columbus, Cincinnati, and the Cleveland suburbs.
Mark Cuban Cost Plus Drugs. The online pharmacy ships to Ohio addresses and lists losartan 50 mg at a transparent markup over manufacturer cost, typically landing around $4 to $5 per month plus a flat shipping fee.
Manufacturer programs. Because losartan is available as a generic, Merck no longer operates a branded Cozaar savings card. However, some generic manufacturers offer patient assistance through NeedyMeds and similar clearinghouses. Ohio residents earning below 200% of the federal poverty level may qualify for free medication through these programs.
Telehealth Prescribing of Losartan in Ohio
Ohio permits telehealth prescribing of losartan. The Ohio State Medical Board recognizes audio-video telemedicine encounters as sufficient for establishing a physician-patient relationship and prescribing non-controlled medications. Losartan is not a controlled substance. No in-person visit is required for an initial prescription in most circumstances.
HealthRX and other telehealth platforms operating in Ohio can evaluate patients for hypertension, order baseline labs (a basic metabolic panel including serum creatinine and potassium is standard before starting an ARB), and write a losartan prescription that can be filled at any Ohio pharmacy. Follow-up monitoring typically includes a repeat metabolic panel 2 to 4 weeks after initiation and periodic blood pressure assessments, which patients can perform with a validated home cuff.
The American Heart Association's 2024 telemedicine position statement endorsed remote management of hypertension with ARBs and other first-line agents, citing evidence that telehealth blood pressure management achieves equivalent outcomes to in-office care when paired with home monitoring. Ohio's telehealth parity law (ORC 3902.30) requires commercial insurers to reimburse telehealth visits at the same rate as in-person visits, removing a financial barrier.
For Ohio patients in rural counties where specialist access is limited, telehealth fills a real gap. Thirty-three of Ohio's 88 counties are classified as medically underserved. A patient in Vinton County (population 13,000, zero cardiologists) can see a HealthRX clinician, get a losartan prescription, and fill it at the local pharmacy for $10 or less.
Losartan Dosing, Monitoring, and Practical Considerations
Standard losartan dosing for hypertension starts at 50 mg once daily for most adults, with a range of 25 mg to 100 mg based on response. The FDA-approved prescribing information specifies 25 mg as the starting dose for patients with hepatic impairment or those on diuretics, and 50 mg for diabetic nephropathy.
Blood pressure response typically appears within one week, with maximal effect at 3 to 6 weeks. If 50 mg does not achieve target blood pressure (<130/80 mmHg per current ACC/AHA guidelines), the dose can be increased to 100 mg daily or a second agent (commonly hydrochlorothiazide or amlodipine) can be added.
Key monitoring requirements:
- Serum potassium. ARBs can raise potassium. Baseline and 2-to-4-week post-initiation levels are standard. Patients with eGFR <45 mL/min need closer monitoring.
- Serum creatinine. A rise of up to 30% from baseline is acceptable and expected. Rises beyond 30% warrant reassessment.
- Blood pressure. Home monitoring with a validated oscillometric device is preferred over office-only measurement. The AHA recommends twice-daily home readings for the first two weeks after initiation.
Losartan interacts with potassium supplements, potassium-sparing diuretics (spironolactone, eplerenone), NSAIDs, and lithium. Ohio pharmacists are required to counsel on these interactions at the point of dispensing.
One clinical nuance: losartan has a shorter half-life (approximately 6 to 9 hours for the active metabolite EXP3174) compared to other ARBs like telmisartan (24 hours) or olmesartan (13 hours). Some patients may benefit from twice-daily dosing of losartan 50 mg rather than once-daily 100 mg if trough blood pressure remains elevated. This dosing adjustment costs the same at most pharmacies since pricing is per-tablet.
Frequently asked questions
›How much does losartan cost in Ohio?
›Does Ohio Medicaid cover losartan?
›Is compounded losartan legal in Ohio?
›Can I get losartan via telehealth in Ohio?
›Which insurance plans cover losartan in Ohio?
›What's the cheapest way to get losartan in Ohio?
›Are there Ohio losartan discount programs?
›How does the Merck savings card work for losartan in Ohio?
›What doses of losartan are available in Ohio?
›Does losartan require lab work before starting?
References
- Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29133356/
- James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults (JNC 8). JAMA. 2014;311(5):507-520. https://pubmed.ncbi.nlm.nih.gov/24352797/
- FDA. Cozaar (losartan potassium) prescribing information. Revised 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020386s062lbl.pdf
- FDA. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). https://www.accessdata.fda.gov/scripts/cder/ob/
- Muntner P, Shimbo D, Carey RM, et al. Measurement of blood pressure in humans: a scientific statement from the American Heart Association. Hypertension. 2019;73(5):e35-e66. https://pubmed.ncbi.nlm.nih.gov/28461599/
- Shimbo D, Artinian NT, Basile JN, et al. Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. Circulation. 2020;142(4):e42-e63. https://pubmed.ncbi.nlm.nih.gov/33853363/
- FDA. Human drug compounding progress report. https://www.fda.gov/drugs/human-drug-compounding/fdas-human-drug-compounding-progress-report